in the half-life and Cmax of drug by using liposomes when compared to marketed gel.
Even they observed sudden decrease in Tmax also. Finally, they concluded the
prepared liposomes helped in better topical delivery of aceclofenac than that of
marketed gel (Sharma et al. 2016a, b).
Yadav et al. developed tamoxifen-loaded polymeric micelles and evaluated the
nanosystems using dermatokinetics. For this study they employed the skin of Laca
mice. They reported that there was 3.4 times enhancement in the bioavailability of
the drug when compared to plain drug. The skin permeation constant was higher in
skin treated with drug-loaded micelles in comparison to the plain drug. Through this
study they concluded that the PLGA-PEG polymer-based nanosystems can help in
increasing the delivery potential of the anti-neoplastic drugs (Yadav et al. 2016).
Sharma et al. developed topical formulation of benzyl benzoate-loaded
microemulsion for treatment of the scabies. They performed dermatokinetic study
using the skin of Laca mice. They found that the nanoformulation helped in
enhancing the Cmax and bioavailability in both the skin layers along with the
reduction in Tmax. From the study they concluded that microemulsion is capable in
Table 14.3 List of lipodermal drugs
Drug carrier
system
Drugs
Disease
Liposomes
Amphotericin B
Fungal infection
Fluconazole
Fungal infection
Calcineurin inhibitors
Prevent DNA photodamage
Ciclopirox
Fungal infection
Methotrexate
Psoriasis
Cetirizine
Pruritus
Lauric acid
Inflammatory acne
Tretinoin
Acne
Idoxuridine
Herpes simplex
Nimesulide
Inflammation and pain
Finasteride
Acne, androgenetic alopecia
Vitamin D analogues: Calcipotriol,
tacalcitol, calcitriol
Antiparakeratosis function
Hydroxyzine
Skin allergy
Tamoxifen
Certain skin disorders
Ethosomes
Fluconazole
Fungal infection
Methotrexate
Psoriasis
Azelaic acid
Acne
Solid lipid
nanoparticles
Cyclosporin A
Allergic skin disorders (atopic
dermatitis)
Nanoemulsion
NB-002
Fungal infection
Nanoparticles
Tacrolimus
Psoriasis
Niosomes
Methotrexate
Psoriasis
Dithranol
Psoriasis
220
R. K. Paul et al.